“Background: Oral anticoagulants reduce embolic complicati


“Background: Oral anticoagulants reduce embolic complications IPI-145 in vivo in patients with atrial fibrillation (AF) and are used in the treatment and prevention of venous thromboembolism. In Poland, chronic oral anticoagulation is usually managed by primary care physicians, and the most commonly used drugs are vitamin K antagonists (VKA).\n\nAim: To evaluate effectiveness of oral anticoagulation in 104 patients receiving chronic VKA treatment in primary care from Jan 01, 2011 to Dec 31, 2011.\n\nMethods: We performed a retrospective analysis of data of 104 patients receiving chronic VKA treatment in a primary care practice (Niepubliczny Zaklad Opieki Zdowotnej ESCULAP Gniewkowo) from Jan 01, 2011

to Dec 31, 2011. These patients comprised 1.1% of the population remaining under care of this primary care practice. We determined minimum, maximum and mean values of the international normalised ratio (INR), the proportion of results

within the therapeutic range, the number of INR measurements, and indications for anticoagulant treatment. In patients with AF, we determined the risks of bleeding complications and thrombotic events.\n\nResults: Among patients receiving chronic VKA treatment, 56.84% of INR measurements were within the therapeutic range. Only 29.8% of patients had more than 70% of INR measurements ACY-738 cost within the therapeutic range. We found no association between the number of INR measurements and treatment effectiveness.\n\nConclusions: The effectiveness of anticoagulation in primary care is unsatisfactory. In our study population, an acceptable time in the therapeutic range was achieved in only just below 30% of patients.”
“Objective: In patients with primary hyperparathyroidism, candidates for surgical intervention, the parathyroid pre-operative localization is of fundamental importance in planning the appropriate surgical approach. Materials and methods:The additional acquisition of SPECT andTechnetium-99m images, during parathyroid scintigraphy MCC950 manufacturer with Sestamibi, is not common practice. Usually, only planar image acquisition, 15 minutes prior and 2

hours after radiopharmaceutical administration, is performed. Results: In our experience, the complete protocol in parathyroid scintigraphy increases the accuracy of pre-operative parathyroid localization. Conclusion: The complete utilization of all available nuclear medicine methods (SPECT e Tc-99m) and image interpretation in a multidisciplinary context can improve the accuracy of parathyroid scintigraphy. Arq Bras Endocrinol Metab. 2010;54(4):352-61″
“Strain JX22, exhibiting a broad range of antimicrobial activities to fungal pathogens, was isolated and classified as representing Pseudomonas kilonensis. In this study, the mutant JX22MT1 was obtained by the EZ-Tn5 transposon mutation and showed no antifungal activity against Fusarium oxysporum f. sp. lycopersici as compared with wild-type strain JX22.

Comments are closed.